🇺🇸 FDA
Pipeline program

Drug-Drug Interaction Study With BIA 28-6156 and Clarithromycin, Midazolam, and Dabigatran Etexilate in Healthy Participants

BIA-28-6156-113

Phase 1 other active

Quick answer

Drug-Drug Interaction Study With BIA 28-6156 and Clarithromycin, Midazolam, and Dabigatran Etexilate in Healthy Participants for Healthy volunteers is a Phase 1 program (other) at BIAL - Portela & Ca with 1 ClinicalTrials.gov record(s).

Program details

Company
BIAL - Portela & Ca
Indication
Healthy volunteers
Phase
Phase 1
Modality
other
Status
active

Clinical trials